These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 240347)

  • 1. The rectal administration of lactulose.
    Ratnaike RN; Hicks EP; Hislop IG
    Aust N Z J Med; 1975 Apr; 5(2):137-40. PubMed ID: 240347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergency treatment of portal-systemic encephalopathy with lactulose enemas. A controlled study.
    Van Waes L; van Egmond J; Demeulenaere L
    Acta Clin Belg; 1979; 34(3):122-9. PubMed ID: 506621
    [No Abstract]   [Full Text] [Related]  

  • 3. Lactulose enemas in the treatment of hepatic encephalopathy. Do we help or harm?
    de Lorenzo-Pinto A; García-Sánchez R; Lorenzo-Salinas A
    Rev Esp Enferm Dig; 2017 Oct; 109(10):736-737. PubMed ID: 28929776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial.
    Conn HO; Leevy CM; Vlahcevic ZR; Rodgers JB; Maddrey WC; Seeff L; Levy LL
    Gastroenterology; 1977 Apr; 72(4 Pt 1):573-83. PubMed ID: 14049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful use of vancomycin hydrochloride in the treatment of lactulose resistant chronic hepatic encephalopathy.
    Tarao K; Ikeda T; Hayashi K; Sakurai A; Okada T; Ito T; Karube H; Nomoto T; Mizuno T; Shindo K
    Gut; 1990 Jun; 31(6):702-6. PubMed ID: 2199349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lactulose and portocaval encephalopathy: value of its administration by rectal route].
    Chevrel B
    Med Chir Dig; 1977; 6(5):309-12. PubMed ID: 916764
    [No Abstract]   [Full Text] [Related]  

  • 7. Lactulose: a crucial element in treating hepatic encephalopathy.
    Gever LN
    Nursing; 1982 Aug; 12(8):76-8. PubMed ID: 6920588
    [No Abstract]   [Full Text] [Related]  

  • 8. Lactulose in the treatment of chronic portal-systemic encephalopathy. A double-blind clinical trial.
    Elkington SG; Floch MH; Conn HO
    N Engl J Med; 1969 Aug; 281(8):408-12. PubMed ID: 4894464
    [No Abstract]   [Full Text] [Related]  

  • 9. Lactitol in the treatment of chronic hepatic encephalopathy: an open comparison with lactulose.
    Lanthier PL; Morgan MY
    Gut; 1985 Apr; 26(4):415-20. PubMed ID: 3979914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enterococcus lactic acid bacteria strain SF68 and lactulose in hepatic encephalopathy: a controlled study.
    Loguercio C; Del Vecchio Blanco C; Coltorti M
    J Int Med Res; 1987; 15(6):335-43. PubMed ID: 3125077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in the levels of ammonia and free phenols in patients with portocaval shunt treated with lactulose and/or neomycin compared to a low protein diet (author's transl)].
    Leonhardt H; Sanhueza P
    Med Klin; 1978 Jan; 73(2):63-8. PubMed ID: 622058
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative modes of action of lactitol and lactulose in the treatment of hepatic encephalopathy.
    Patil DH; Westaby D; Mahida YR; Palmer KR; Rees R; Clark ML; Dawson AM; Silk DB
    Gut; 1987 Mar; 28(3):255-9. PubMed ID: 3570029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of chronic portal-systemic encephalopathy with lactulose. Report of six patients and review of the literature.
    Bircher J; Haemmerli UP; Scollo-Lavizzari G; Hoffmann K
    Am J Med; 1971 Aug; 51(2):148-59. PubMed ID: 5095524
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative study of basal arterial ammonemia and of orally-induced hyperammonemia in chronic portal systemic encephalopathy, treated with neomycin, lactulose, and an association of neomycin and lactulose.
    Pirotte J; Guffens JM; Devos J
    Digestion; 1974; 10(6):435-44. PubMed ID: 4448315
    [No Abstract]   [Full Text] [Related]  

  • 15. Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial.
    Atterbury CE; Maddrey WC; Conn HO
    Am J Dig Dis; 1978 May; 23(5):398-406. PubMed ID: 354373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lactulose (cephulac) in portosystemic encephalopathy.
    Kosman ME
    JAMA; 1976 Nov; 236(21):2444-5. PubMed ID: 989871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hyperammoniemia and porta-caval encephalopathy in patients with cirrhosis. Personal results of lactulose treatment].
    Butti A; Bianco S; Bergonzi P; Cagossi M; Civello IM; Borzone A; Nanni G; Pigliucci GM
    Chir Patol Sper; 1975 Apr; 23(2):77-95. PubMed ID: 1140038
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of lactulose treatment on the course of subclinical hepatic encephalopathy].
    Zeng Z; Li YY
    Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(13):1126-9. PubMed ID: 12921628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of lactulose, neomycin and antacid on colonic pH recorded continuously with an implanted electrode.
    Mann NS; Borkar BB; Narenderan KP; Kadian RS; Mann SK; Martin RL
    Am J Gastroenterol; 1979 Aug; 72(2):141-5. PubMed ID: 38663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lactulose enemas.
    Kersh ES; Rifkin H
    Ann Intern Med; 1973 Jan; 78(1):81-4. PubMed ID: 4682313
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.